TNM and FIGO Classifications for Cervical Cancer
The American Joint Committee on Cancer (AJCC) TNM classification and the International Federation of Gynecology and Obstetrics (FIGO) staging system for cervical cancer are provided below. [1, 2, 3]
Table 1. TNM and FIGO Classifications for Cervical Cancer (Open Table in a new window)
Primary tumor (T) |
||
TNM |
FIGO |
Surgical-Pathologic Findings |
Categories |
Stages |
|
TX |
|
Primary tumor cannot be assessed |
T0 |
|
No evidence of primary tumor |
Tis |
|
Carcinoma in situ (preinvasive carcinoma) |
T1 |
I |
Cervical carcinoma confined to the cervix (disregard extension to the corpus) |
T1a |
IA |
Invasive carcinoma diagnosed only by microscopy; stromal invasion with a maximum depth of < 5.0 mm, measured from the base of the epithelium; vascular space involvement, venous or lymphatic, does not affect classification
|
T1a1 |
IA1 |
Measured stromal invasion < 3.0 mm in depth |
T1a2 |
IA2 |
Measured stromal invasion ≥ 3.0 mm and < 5.0 mm |
T1b |
IB |
Invasive carcinoma with measured deepest invasion ≥ 5 mm (greater than stage IA), lesion limited to the cervix |
T1b1 |
IB1 |
Invasive carcinoma with ≥ 5 mm depth of stromal invasion and < 2 cm in greatest dimension |
T1b2 |
IB2 |
Invasive carcinoma, 2 cm to < 4 cm in greatest dimension |
T1b3 |
IB3 |
Invasive carcinoma, ≥ 4 cm in greatest dimension |
T2 |
II |
Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina |
T2a |
IIA |
Involvement limited to the upper two-thirds of the vagina, without parametrial invasion |
T2a1 |
IIA1 |
Invasive carcinoma < 4 cm in greatest dimension |
T2a2 |
IIA2 |
Invasive carcinoma ≥ 4 cm in greatest dimension |
T2b |
IIB |
Tumor with parametrial invasion but not up to the pelvic wall |
T3 |
III |
Carcinoma involves the lower third of the vagina and/or extends to the pelvic wall and/or causes hydronephrosis or nonfunctioning kidney and/or involves pelvic and/or para-aortic lymph nodes |
T3a |
IIIA |
Tumor involves lower third of vagina, with no extension to pelvic wall |
T3b |
IIIB |
Tumor extends to pelvic wall and/or causes hydronephrosis or nonfunctional kidney |
T3c |
IIIC |
Involvement of pelvic and/or para-aortic lymph nodes, irrespective of tumor size and extent (with r [imaging] and p [pathology] notations) |
T3c1 |
IIIC1 |
Pelvic lymph node metastasis only |
T3c2 |
IIIC2 |
Para-aortic lymph node metastasis |
T4 |
IV |
The carcinoma has extended beyond the true pelvis or has involved (biopsy proven) the mucosa of the bladder or rectum. (A bullous edema, as such, does not permit a case to be allotted to stage IV.) |
|
IVA |
Spread to adjacent pelvic organs |
|
IVB |
Spread to distant organs |
Regional lymph nodes (N) |
||
NX |
Regional lymph nodes cannot be assessed |
|
N0 |
No regional lymph node metastasis |
|
N0 (i+) |
Isolated tumor cells in regional lymph node(s) ≤ 0.2 mm |
|
N1 |
Regional lymph node metastasis |
|
Distant metastasis (M) |
||
M0 |
No distant metastasis |
|
M1 |
Distant metastasis (including peritoneal spread; involvement of supraclavicular, mediastinal, or distant lymph nodes; and lung, liver, or bone) |
Table 2. AJCC Prognostic Groups (Open Table in a new window)
Stage |
Tumor |
Node |
Metastasis |
I |
T1 |
Any N |
M0 |
IAI |
T1a |
Any N |
M0 |
IA2 |
T1a1 |
Any N |
M0 |
IB |
T1b |
Any N |
M0 |
IB1 |
T1b1 |
Any N |
M0 |
IB2 |
T1b2 |
Any N |
M0 |
II |
T2 |
Any N |
M0 |
IIA |
T2a |
Any N |
M0 |
IIA1 |
T2a1 |
Any N |
M0 |
IIA2 |
T2a2 |
Any N |
M0 |
IIB |
T2b |
Any N |
M0 |
III |
T3 |
Any N |
M0 |
IIIA |
T3a |
Any N |
M0 |
IIIB |
T3b |
Any N |
M0 |
IVA |
T4 |
Any N |
M0 |
IVB |
Any T |
Any N |
M1 |